These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4913637)

  • 1. Tolbutamide: hazards of leaks.
    Nature; 1970 Jul; 227(5255):224-5. PubMed ID: 4913637
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolbutamide study raises blood pressures.
    Nature; 1970 Dec; 228(5278):1251-2. PubMed ID: 5536884
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled clinical trials and the tolbutamide controversy.
    Lavietes PH
    Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug fears dismissed.
    Nature; 1970 Nov; 228(5272):599. PubMed ID: 4920015
    [No Abstract]   [Full Text] [Related]  

  • 5. The FDA and hypoglycemic drugs.
    Davidson JK
    JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: The UGDP scandal and cover-up.
    Moss JM
    JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
    [No Abstract]   [Full Text] [Related]  

  • 7. "Settling the UGDP controversy"?
    Bradley RF; Dolger H; Forsham PH; Seltzer H
    JAMA; 1975 May; 232(8):813-7. PubMed ID: 1091759
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolbutamide: another view.
    Nahum LH
    Conn Med; 1971 Apr; 35(4):272-3. PubMed ID: 5108037
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversy over study of diabetes drugs continues for nearly a decade.
    Kolata GB
    Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980
    [No Abstract]   [Full Text] [Related]  

  • 11. The oral hypoglycemic controversy. Stay as sweet as you are.
    Gregory DR
    Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
    [No Abstract]   [Full Text] [Related]  

  • 12. The tolbutamide controversy.
    Compr Ther; 1975 May; 1(1):19-20. PubMed ID: 1222531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heart death and oral antidiabetics; the last judgement].
    Touber JL
    Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Let's stop the Donnybrook. A perspective on the UGDP-Biometric Society Study.
    Moser RH
    JAMA; 1975 Mar; 231(12):1274-6. PubMed ID: 1172958
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 16. Status of problem of usage of tolbutamide. Preliminary statements.
    Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
    [No Abstract]   [Full Text] [Related]  

  • 17. The University Group Diabetes Program. A statistician looks at the mortality results.
    Schor S
    JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolbutamide: more questions than answers.
    Barclay WR
    JAMA; 1971 Jan; 215(1):108-9. PubMed ID: 5107341
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical guest editorial: The oral diabetic drug controversy.
    Am Fam Physician; 1975 Dec; 12(6):73-4. PubMed ID: 1202930
    [No Abstract]   [Full Text] [Related]  

  • 20. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.